EUVIMEDEUVIMED entdecken
Crossref

Fullerene (C 60 & C 70 )‐ Meso ‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C

Debdulal Sharma, Madhu Rai, Aradhana Singh, Ritu Gaur iD, Devashish Senguptaa iD

Journal of Medical Virology · 2025-02 · 97 (2)

DOI: 10.1002/jmv.70181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 27.01.2025. Verfasst von Debdulal Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Assam University, Silchar, India. Hauptthemen laut MEDLINE: HIV-1, Porphyrins, Fullerenes, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: The support by DBT (Nanobiotechnology) Project Reg. No: BT/PR25024/NER/95/961/2017, granted to Devashish Sengupta by the Department of Biotechnology, Ministry….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The biological applications of noncationic porphyrin‐fullerene (P‐F) dyads as anti‐HIV agents have been limited despite the established use of several cationic P‐F dyads as anti‐cancer photodynamic therapy (PDT) agents. This article explores the potential of amphiphilic non‐cationic porphyrin‐fullerene dyads as HIV‐1 inhibitors under both PDT (light‐treated) and non‐PDT (dark) conditions. The amphiphilic P‐F dyads, PB 3 C 60 and PB 3 C 70 , demonstrated enhanced efficacy in inhibiting the entry and production of HIV‐1 (subtypes B and C). Under light‐harvested conditions, the dyads exhibited potent inhibitory effects (EC 50 for PB 3 C 60 and PB 3 C 70 < 10 nM) and also maintained significant inhibition under non‐PDT conditions (EC 50 for PB 3 C 60 = 1.43 μM and PB 3 C 70 = 1.50 μM), while displaying notably reduced toxicity compared to their water‐soluble porphyrin precursor. The P‐F dyads exhibited substantial efficacy in neutralizing the T20‐resistant strain 9491, both at the entry and postentry phases, thereby addressing the challenge of drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1PorphyrinsFullerenesAnti-HIV AgentsVirus InternalizationHumansDrug Resistance, ViralHIV InfectionsCell Line

Stichwörter der Autor:innen

T20‐resistant HIV‐1anti‐HIVdonor‐acceptor combinationsphotoinhibitionporphyrin‐fullerene dyads

Substanzen

PorphyrinsFullerenesAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Chemistry, Assam University, Silchar, India.
  • Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India.

ORCID-Profile: Ritu Gaur, Devashish Senguptaa

Förderung

  • The support by DBT (Nanobiotechnology) Project Reg. No: BT/PR25024/NER/95/961/2017, granted to Devashish Sengupta by the Department of Biotechnology, Ministry…

Zitieren

APA

Sharma, D., Rai, M., Singh, A., Gaur, R., & Senguptaa, D. (2025). Fullerene (C 60 & C 70 )‐ Meso ‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70181

Vancouver

Sharma D, Rai M, Singh A, Gaur R, Senguptaa D. Fullerene (C 60 & C 70 )‐ Meso ‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70181

BibTeX
@article{Sharma2025,
  author = {Sharma, Debdulal and Rai, Madhu and Singh, Aradhana and Gaur, Ritu and Senguptaa, Devashish},
  title = {Fullerene (C 60 & C 70 )‐ Meso ‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {2},
  doi = {10.1002/jmv.70181}
}
Kostenlos starten →